Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, Frahm N, Hural J, Anude C, Graham BS, Enama ME, Adams E, DeJesus E, Novak RM, Frank I, Bentley C, Ramirez S, Fu R, Koup RA, Mascola JR, Nabel GJ, Montefiori DC, Kublin J, McElrath MJ, Corey L, Gilbert PB; HVTN 505 Study Team. Hammer SM, et al. Among authors: sobieszczyk me. N Engl J Med. 2013 Nov 28;369(22):2083-92. doi: 10.1056/NEJMoa1310566. Epub 2013 Oct 7. N Engl J Med. 2013. PMID: 24099601 Free PMC article. Clinical Trial.
AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection.
Aksyuk AA, Bansal H, Wilkins D, Stanley AM, Sproule S, Maaske J, Sanikommui S, Hartman WR, Sobieszczyk ME, Falsey AR, Kelly EJ. Aksyuk AA, et al. Among authors: sobieszczyk me. Cell Rep Med. 2023 Jan 17;4(1):100882. doi: 10.1016/j.xcrm.2022.100882. Epub 2022 Dec 15. Cell Rep Med. 2023. PMID: 36610390 Free PMC article.
Implementation and resource needs for long-acting PrEP in low- and middle-income countries: a scoping review.
Castor D, Heck CJ, Quigee D, Telrandhe NV, Kui K, Wu J, Glickson E, Yohannes K, Rueda ST, Bozzani F, Meyers K, Zucker J, Deacon J, Kripke K, Sobieszczyk ME, Terris-Prestholt F, Malati C, Obermeyer C, Dam A, Schwartz K, Forsythe S. Castor D, et al. Among authors: sobieszczyk me. J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26110. doi: 10.1002/jia2.26110. J Int AIDS Soc. 2023. PMID: 37439063 Free PMC article. Review.
Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19: A Case-Control Study in New York City.
Thakur KT, Chu VT, Hughes C, Kim CY, Fleck-Derderian S, Barrett CE, Matthews E, Balbi A, Bilski A, Chomba M, Lieberman O, Jacobson SD, Agarwal S, Roh D, Park S, Ssonko V, Silver WG, Vargas WD, Geneslaw A, Bell M, Waters B, Rao A, Claassen J, Boehme A, Willey JZ, Elkind MSV, Sobieszczyk ME, Zucker J, McCollum A, Sejvar J. Thakur KT, et al. Among authors: sobieszczyk me. Neurol Clin Pract. 2022 Aug;12(4):e66-e74. doi: 10.1212/CPJ.0000000000200006. Neurol Clin Pract. 2022. PMID: 36382116 Free PMC article.
Back2PrEP: Rates of Bacterial Sexually Transmitted Infection Diagnosis Among Individuals Returning to HIV Pre-Exposure Prophylaxis Care: A Retrospective Review of a New York City Comprehensive HIV Prevention Program.
McLean J, Bartram L, Zucker J, LaSota E, Carnevale C, Richards P, Perez E, Mori K, Mgbako O, Olender S, Cohall A, Gordon P, Sobieszczyk M. McLean J, et al. AIDS Patient Care STDS. 2022 Dec;36(12):458-461. doi: 10.1089/apc.2022.0169. Epub 2022 Nov 16. AIDS Patient Care STDS. 2022. PMID: 36383140 Free PMC article.
Advances in antiretroviral therapy.
Sobieszczyk ME, Talley AK, Wilkin T, Hammer SM. Sobieszczyk ME, et al. Top HIV Med. 2005 Mar-Apr;13(1):24-44. Top HIV Med. 2005. PMID: 15849370 Free article.
Advances in antiretroviral therapy.
Sobieszczyk ME, Jones J, Wilkin T, Hammer SM. Sobieszczyk ME, et al. Top HIV Med. 2006 Mar-Apr;14(1):36-62. Top HIV Med. 2006. PMID: 16641526 Free article.
127 results